Diane 35
developed to target androgen-mediated skin conditions, to alleviate acne symptoms.
Strengths: 2/0.035mg
Where to Check Availability
Medicine details
- Alternative names
Dianette; Cyproterone Acetate and Ethinylestradiol Tablets
- Therapeutic class
Antiandrogen; Oestrogen/Progestogen
- Pharmacological class
Antiandrogen; Oestrogen
- Contraindications
venous thromboembolism; history of breast cancer; liver tumours; pregnancy
- Precautions and warnings
risk of blood clots; screen for risk factors prior to use
- Minor side effects
nausea; breast tenderness; headache
- Moderate side effects
mood changes; weight changes
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Bayer
- Onset Time
3+ months
- Duration
daily
- Storage instructions
Store at room temperature in a dry place.
- Drug interactions
antiepileptics; st. john's wort
- Age restrictions
Post-pubertal use only.
- Pregnancy and breastfeeding
Pregnancy: Contraindicated. Breastfeeding: Not recommended.
Serious side effects
thrombosis — requires immediate medical attention; pulmonary embolism — requires immediate medical attention
Patient summary
developed to target androgen-mediated skin conditions, to alleviate acne symptoms.
Mechanism of action
Cyproterone acetate blocks androgen receptors and reduces androgen production, while ethinylestradiol increases sex hormone-binding globulin, decreasing free androgen levels to manage acne and hirsutism.
Diane 35
developed to target androgen-mediated skin conditions, to alleviate acne symptoms.
Editorial Notes
- Active ingredient(s): Cyproterone, Ethinylestradiol
- Listed indication(s): Acne, Hirsutism
Available option
- 105 tablets - 2/0.035 mg1276-2-0-035-mg-15204